Young-Onset Colorectal Cancer

Running, not enrolling

Conditions studied: Colon Adenocarcinoma, Colorectal Carcinoma, Rectal Adenocarcinoma

In brief

This study investigates the genetic factors that may influence the risk of developing colorectal cancer at a young age. Finding genetic markers for colorectal may help identify patients who are at risk of colorectal cancer. Studying individuals and families at high risk of cancer may help identify cancer genes and other persons at risk.

Key facts

Study ID

NCT02863107

Run by

M.D. Anderson Cancer Center

People needed

818

Starts

2012-06-07

Expected to finish

2030-08-31

Last updated by the study team

2026-04-16

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• PATIENTS: MDACC patients who have adenocarcinoma of the colon or rectum, diagnosed between ages 18 through 50 (young-onset), or diagnosed at age 51 through 80 (later-onset)
• PATIENTS: Patient must have sufficient command of the English language and mental capacity to provide consent
• FAMILY MEMBERS: Be a parent, sibling or child (first degree blood relative) of a registered MDACC patient meeting eligibility criteria above
• FAMILY MEMBERS: Have sufficient command of the English language and mental capacity to provide consent
• FAMILY MEMBERS: Family member must be at least 18 years of age at the time of study registration

Where it is running

• MD Anderson in The Woodlands — Conroe, Texas, United States
• M D Anderson Cancer Center — Houston, Texas, United States
• MD Anderson West Houston — Houston, Texas, United States
• MD Anderson League City — League City, Texas, United States
• MD Anderson in Sugar Land — Sugar Land, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.